Women with endometriosis may soon benefit from quicker diagnosis thanks to new tests that GPs can offer, potentially reducing the current average diagnosis wait time of over nine years. The National Institute for Health and Care Excellence (NICE) has endorsed two non-invasive tests that could significantly speed up the diagnostic process.
Endometriosis, a painful condition affecting about one in 10 women of reproductive age in the UK, involves abnormal cell growth outside the womb’s lining, leading to symptoms like pelvic pain, heavy periods, fatigue, and infertility. The approved tests, EndoSure and Endotest, will be available on the NHS for a three-year trial period to assess their effectiveness. While not all GP practices will have immediate access, patients without direct access can still be overseen by healthcare professionals with expertise in diagnosing endometriosis.
Endotest analyzes saliva samples for microRNAs associated with endometriosis, while EndoSure measures gut electrical signals using abdominal sensor pads. Although these tests alone cannot diagnose endometriosis, they are expected to help identify individuals requiring further investigation and treatment promptly.
The initiative follows a survey by the All-Party Parliamentary Group on Endometriosis, revealing that many women visited their GPs multiple times before receiving a diagnosis, with some even resorting to A&E visits due to symptoms. Dr. Anastasia Chalkidou from NICE emphasized the potential of these tests to provide primary care professionals with improved tools for early endometriosis detection, facilitating quicker and better treatment for affected individuals.
One success story involves Simran Chavda, a 15-year-old from Huddersfield, West Yorkshire, who underwent years of diagnostic uncertainty before her mother, Sharan Uppal, opted for the gut test that led to a positive diagnosis. Simran expressed relief upon finally understanding her condition, highlighting the simplicity of the test and her improved well-being post-surgery.
Dr. Gail Busby, a consultant gynaecologist at Manchester University NHS Foundation Trust, emphasized the life-altering impact of early endometriosis diagnosis, not only for individual patients but also for optimizing healthcare resources by reducing wait times for others in need of care.